IONIS PHARMACEUTICALS, INC.
Sign in to add to a watchlist →
lobbying_client · US · canonical: ionis pharmaceuticals · 2 aliases · 9 outbound · 7 inbound
Activity
Every typed-graph event involving this entity, newest first. Each row is one edge in the influence graph; click the date to jump to its provenance.
- 2026-05-18 · lobbied by Jordan Chapman · lda_lobbyist_client
- 2026-05-18 · lobbied by Sophie Khanahmadi · lda_lobbyist_client
- 2026-05-18 · lobbied by Sonia Goh · lda_lobbyist_client
- 2026-05-18 · lobbied by Maximilian Walter · lda_lobbyist_client
- 2026-05-18 · lobbied by Alanna Temme · lda_lobbyist_client
- 2026-01-01 · lobbied on Cameron’s Law (h.r.1414) · lobbying_bill_mention
- 2026-01-01 · lobbied on Mikaela Naylon Give Kids a Chance Act (h.r.1262) · lobbying_bill_mention
- 2026-01-01 · lobbied on ORPHAN Cures Act (s.1862) · lobbying_bill_mention
- 2026-01-01 · lobbied on Give Kids a Chance Act of 2025 (s.932) · lobbying_bill_mention
- 2026-01-01 · lobbied on Mikaela Naylon Give Kids a Chance Act (h.r.1262) · lobbying_bill_mention
- 2026-01-01 · lobbied for by IONIS PHARMACEUTICALS, INC. $150,000 · lda_filing
- 2026-01-01 · lobbied on ORPHAN Cures Act (h.r.946) · lobbying_bill_mention
- 2026-01-01 · lobbied on Maintaining Investments in New Innovation Act (h.r.1672) · lobbying_bill_mention
- 2026-01-01 · lobbied for by LMH STRATEGIC SOLUTIONS $30,000 · lda_filing
- 2026-01-01 · lobbied on Give Kids a Chance Act of 2025 (s.932) · lobbying_bill_mention
- 2026-01-01 · lobbied on Maintaining Investments in New Innovation Act (h.r.1672) · lobbying_bill_mention
Lobbying disclosures — as CLIENT (2)
Filings where this org hired a lobbying firm. Income + expenses come from the LDA disclosure.
| Posted | Filing | Year | Period | Registrant (lobbying firm) | Income | Expenses |
|---|---|---|---|---|---|---|
| 2026-04-17 | 1st Quarter - Report | 2026 | first_quarter | 401108183 | $30,000 | — |
| 2026-04-09 | 1st Quarter - Report | 2026 | first_quarter | 401108715 | — | $150,000 |
Aliases (2)
| source | id | name at source | jurisdiction | confidence | linked by | linked at |
|---|---|---|---|---|---|---|
| lda_client | 61064 | IONIS PHARMACEUTICALS, INC. | US | gold | backfill_0029 | |
| lda_client | 61063 | IONIS PHARMACEUTICALS, INC. | US | gold | backfill_0029 |
Outbound edges (9)
| date | type | to | amount | role | source |
|---|---|---|---|---|---|
| 2026-01-01 | lobbies_on_bill | HR 1262 — Mikaela Naylon Give Kids a Chance Act | — | H.R.1262 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1672 — Maintaining Investments in New Innovation Act | — | H.R.1672 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 946 — ORPHAN Cures Act | — | H.R.946 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 1862 — ORPHAN Cures Act | — | S.1862 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 932 — Give Kids a Chance Act of 2025 | — | S.932 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1262 — Mikaela Naylon Give Kids a Chance Act | — | H.R.1262 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1414 — Cameron’s Law | — | H.R.1414 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | HR 1672 — Maintaining Investments in New Innovation Act | — | H.R.1672 | lobbying_bill_mention |
| 2026-01-01 | lobbies_on_bill | S 932 — Give Kids a Chance Act of 2025 | — | S.932 | lobbying_bill_mention |
Inbound edges (7)
| date | from | type | amount | source |
|---|---|---|---|---|
| — | Sophie Khanahmadi | lobbied_for | — | lda_lobbyist_client |
| — | Maximilian Walter | lobbied_for | — | lda_lobbyist_client |
| — | Sonia Goh | lobbied_for | — | lda_lobbyist_client |
| — | Alanna Temme | lobbied_for | — | lda_lobbyist_client |
| — | Jordan Chapman | lobbied_for | — | lda_lobbyist_client |
| 2026-01-01 | IONIS PHARMACEUTICALS, INC. | lobbies_for | $150,000 | lda_filing |
| 2026-01-01 | LMH STRATEGIC SOLUTIONS | lobbies_for | $30,000 | lda_filing |